SCHEMBL7657987

SCHEMBL7657987

OCC(O)COCc1ccc(COCC(O)CO)nc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 4/20 0.39
CA2 P00918 2/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CYP1A2 P05177 3/20 0.38
AGTR1 P30556 1/20 0.38
LMNA P02545 1/20 0.38
HTT P42858 2/20 0.37
USP2 O75604 1/20 0.37
GAA P10253 1/20 0.37
MAPK1 P28482 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
S1PR1 P21453 1/20 0.36
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
AGER Q15109 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7650161 0.86 CA1 (0.35) CA1CA2CA7CA9HTT
SCHEMBL7656741 0.85 CSF1R (0.33) CA1CA2CA7CA9RAB9A
SCHEMBL7106145 0.83 CYP1A2 (0.37) CA1CA2CA7CA9CYP1A2
SCHEMBL7104782 0.83 CYP1A2 (0.37) CA1CA2CA7CA9CYP1A2
SCHEMBL19669710 0.83 CYP1A2 (0.37) CA1CA2CA7CA9CYP1A2
SCHEMBL7655274 0.76 NPC1 (0.34) LMNAUSP2MAPK1RAB9ASMN1; SMN2
SCHEMBL11473096 0.74 PRMT5 (0.55) CA1CA2CA7CA9CYP1A2
SCHEMBL7103431 0.74 USP2 (0.35) CA1CA2CA7CA9CYP1A2
SCHEMBL7103428 0.74 USP2 (0.35) CA1CA2CA7CA9CYP1A2
SCHEMBL3414949 0.73 CA1 (0.47) CA1CA2CA7CA9CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US claimed
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US disclosed